TAM (Treatments and Medicines) NHS Highland
Important: Therapy notes
MHRA advice: Janus kinase (JAK) inhibitors: new measures to reduce risks of major cardiovascular events, malignancy, venous thromboembolism, serious infections and increased mortality (April 2023).
Important: Formulation and dosage details
Formulation:
Capsules 50mg (Restricted: Specialist initiation only)
Dosage:
As per SMC 2610: For the treatment of severe alopecia areata in adults and adolescents 12 years of age and older.
For the management of alopecia, see Dermatology patient pathways: Alopecia.
Homecare is the preferred option - contact nhsh.homecare@nhs.scot.